Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...
SEATTLE — A Tacoma teenager is celebrating a second lease on life, thanks to an extraordinary gift from her sister.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback